Showing results (611-620 of 1,303) with videos related to
Sort By:
Pageof 131
Journal of Gynecologic Oncology|March 3, 2026
Homologous recombination deficiency in high-grade serous ovarian carcinoma: clinical pathological characteristics, impact of neoadjuvant chemotherapy, and prognostic implicationsYunjie Ge, Yangyang He, Shili Yu, et al.Journal of Gynecologic Oncology|March 30, 2026
One more opportunity in early-stage cervical cancer: the role of photodynamic therapy in managing positive surgical marginsAlexander Dushkin, Tatyana Grishacheva, Stanislav Afanasiev, et al.Journal of Gynecologic Oncology|March 30, 2026
The impact of cervicovaginal microbiome on HPV infection in vaccinated young Korean womenJaehyun Cho, Sorim Do, Kyunghoon Kim, et al.Journal of Gynecologic Oncology|April 10, 2026
Adjuvant concurrent chemoradiotherapy for early-stage cervical cancer patients with intermediate-risk factors in the era of intensity-modulated radiation therapySitong Wang, Gui-Fen Ma, Chunli Xiao, et al.Journal of Gynecologic Oncology|April 10, 2026
Outcomes of node-positive cervical cancer treated with neoadjuvant chemotherapy followed by radical surgery: a single-center approach to a challenging diseaseInnocenza Palaia, Giorgia Perniola, Noemi Tonti, et al.Journal of Gynecologic Oncology|April 10, 2026
Prognostic significance of psoas muscle index at diagnosis in cervical cancer progressionSeon-Mi Lee, Hyunkyoung Seo, Seongmin Kim, et al.Journal of Gynecologic Oncology|April 17, 2026
P16/Ki67 dual staining versus cytology for identifying high-grade cervical intraepithelial neoplasia (CIN2+/CIN3+) in triage management of HR-HPV-positive women: a systematic review and meta-analysisHang Zhou, Yu Dai, Hua Zhang, et al.Journal of Gynecologic Oncology|April 17, 2026
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: vaginal cancer sub cohort resultsYoung Kwang Chae, Josie Czeskleba, Sandip Pravin Patel, et al.Journal of Gynecologic Oncology|May 11, 2026
Type-specific detection and quantification of circulating tumor HPV DNA by digital PCR in surgically resected cervical cancerAsami Matsunaga, Miho Ogawa, Akiko Kunita, et al.Journal of Gynecologic Oncology|May 15, 2026
Trastuzumab deruxtecan in HER2-expressing gynecologic cancers from DESTINY-PanTumor02: antitumor activity, safety, and exploratory biomarker analysesJung-Yun Lee, Ana Oaknin, Luis Manso, et al.Pageof 131